NHS Trust has been presented with the Insulin Safety Week Excellence Award in recognition of its outstanding contribution to ...

People with type 1 diabetes using multiple daily injections who respond more consistently to smart insulin pen alerts could ...

New guidance on the management of type 1 diabetes in adults has put greater emphasis on accurate diagnosis amid concerns that ...

Spirit Health and manufacturing partner i-SENS are celebrating CareSens Air achieving the maximum 5/5 study design score in ...

A study by an international group of researchers finds popular diabetes and weight-loss drugs are not linked to pregnancy ...

The Cambridge Diabetes Education Programme (CDEP) has launched a new competency-based training topic to give hospital trusts ...

Debbie Hicks is stepping down as Chair of Trend Diabetes after almost two decades with the organisation, as she prepares to ...

New real-world data to be presented at EASD 2026 suggest continuous glucose monitoring could have benefits extending beyond ...

A new framework which categorises the outcomes of type 2 diabetes could be instrumental in the drive to alter the progression ...

Healthcare professionals are being offered new educational support to help recognise chronic kidney disease (CKD) earlier and ...

Four technology appraisals for type 2 diabetes have been updated, and guidance on 4 further medicines is being withdrawn, as part of NICE’s first test of a new way of keeping all its guidance aligned.

We have received funding by means of sponsorship from multiple pharmaceutical companies and MedTech industries to support the delivery of our national conference. The sponsoring companies are Abbott, ...